AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Introduction
Exploring the potential of Gali Medix Therapeutics' small molecule GAL201 in treating Alzheimer's disease, showing neuroprotective effects and cognitive function improvements through alpha-beta aggregation modulation, promising a new drug candidate for clinical advancement.